Related references
Note: Only part of the references are listed.Current status of gene therapy trials for Parkinson's disease
Massimo Fiandaca et al.
EXPERIMENTAL NEUROLOGY (2008)
Parkinson's disease: genetic versus toxin-induced rodent models
Muegen Terzioglu et al.
FEBS JOURNAL (2008)
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
William J. Marks et al.
LANCET NEUROLOGY (2008)
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
J. L. Eberling et al.
NEUROLOGY (2008)
Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease
Mathieu Marella et al.
PLOS ONE (2008)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Mats I. Ekstrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Jason R. Richardson et al.
TOXICOLOGICAL SCIENCES (2007)
Neuroprotection in Parkinson models varies with toxin administration protocol
David W. Anderson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Parkinson's disease: a rethink of rodent models
Heather L. Melrose et al.
EXPERIMENTAL BRAIN RESEARCH (2006)
Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?
T Yagi et al.
REJUVENATION RESEARCH (2006)
In vivo complementation of complex I by the yeast Ndi1 enzyme -: Possible application for treatment of Parkinson disease
Byoung Boo Seo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Possibility of transkingdom gene therapy for Complex I diseases
Takao Yagi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Intersecting pathways to neurodegeneration in Parkinson's disease:: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin-proteasome system
R Betarbet et al.
NEUROBIOLOGY OF DISEASE (2006)
Expanding insights of mitochondrial dysfunction in Parkinson's disease
PM Abou-Sleiman et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
R Iancu et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease
R Kurosaki et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo:: A potential therapy for complex I deficiencies
BB Seo et al.
HUMAN GENE THERAPY (2004)
MPTP as a mitochondrial neurotoxic model of Parkinson's disease
S Przedborski et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway
MW Jakowec et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Mechanism of toxicity in rotenone models of Parkinson's disease
TB Sherer et al.
JOURNAL OF NEUROSCIENCE (2003)
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
GE Meredith et al.
BRAIN RESEARCH (2002)
MPTP - Insights into parkinsonian neurodegeneration
SG Speciale
NEUROTOXICOLOGY AND TERATOLOGY (2002)
A single-subunit NADH-Quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition
BB Seo et al.
MOLECULAR THERAPY (2002)
Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene
YD Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment
E Petroske et al.
NEUROSCIENCE (2001)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells
BB Seo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
